JPRN-UMIN000007790
Completed
Phase 3
A randomized trial of adjuvant chemotherapy in resected stage I lung adenocarcinoma with high SUV index. JNETS 1201 - Adjuvant chemotherapy in lung adenocarcinoma with high SUV index. JNETS 1201
Japanese Northern East Area Thoracic Surgery Study Group (JNETS-SG)0 sites460 target enrollmentApril 20, 2012
Conditionsung cancer
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- ung cancer
- Sponsor
- Japanese Northern East Area Thoracic Surgery Study Group (JNETS-SG)
- Enrollment
- 460
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •non\-p\-stage I lung adenocarcinoma with SUV index with 1 or more.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Randomized clinical trial of adjuvant chemotherapy for cancerbreast with recurrence Loco regional Recessed Radically chemo therapy vs. observatio-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-079-03INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG,
Completed
Phase 2
A randomized clinical trial of adjuvant chemotherapy with TS-1 versus UFT following curative operation for Stage III colorectal cancerstage III colorectal cancerJPRN-C000000346Boso Clinical Oncology Group200
Completed
Phase 2
A Randomized Trial of Adjuvant Chemotherapy with UFT / LV versus PSK / UFT / LV following curative resection for Stage II / III Colorectal Cancercolorectal cancerJPRN-UMIN000005484Gunma University Graduate School of Medicine Department of Thoracic and Visceral Organ Surgery200
Active, not recruiting
Phase 2
Randomized Phase II study of adjuvant chemotherapy with GC versus GS in patients with BTC undergoing curative resection without major hepatectomybiliary tract cancerBiliary tract cancer undergoing curative resection without major hepatectomyJPRN-jRCTs051190040Yanagimoto Hiroaki106
Completed
Phase 2
Randomized Phase II study of adjuvant chemotherapy with gemcitabine plus cisplatin versus gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy(KHBO1901)biliary tract cancerJPRN-UMIN000036449Kansai Hepatobiliary Oncology Group (KHBO)106